| Filed On | Filing |
|---|---|
| 14 Sep 2026 |
8-K: Submission of Matters to a Vote of Security Holders
Polaryx Therapeutics, Inc. (the “Company”), held its Annual Meeting of Stockholders on Thursday, September 10, 2026. For more information on the following proposals, refer to the Company’s Proxy Statement filed with the Securities and Ex... |
| 01 Sep 2026 | 8-K: Regulation FD Disclosure; Other Events |
| 21 Jul 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 17 Jul 2026 | 8-K: Shareholder Director Nominations; Other Events |
| 28 May 2026 | 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more |
Loading...
